Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H19N |
Molecular Weight | 237.3395 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(CN)=C(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=WNKCJOWTKXGERE-UHFFFAOYSA-N
InChI=1S/C17H19N/c1-2-14(13-18)17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12H,2,13,18H2,1H3
Molecular Formula | C17H19N |
Molecular Weight | 237.3395 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/14254672
Sources: http://www.ncbi.nlm.nih.gov/pubmed/14254672
Gilutensin is a drug that was developed for the treatment of hypotensive circulatory disorders. As there is no information available on the drug since 1970, its development is supposed to be terminated in early phase.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:28:44 UTC 2023
by
admin
on
Fri Dec 15 16:28:44 UTC 2023
|
Record UNII |
1ZFB1FR98E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70187690
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
CHEMBL2104621
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
SUB07300MIG
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
100000082074
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
68840
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
2694
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
C65575
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
1ZFB1FR98E
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
341-00-4
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
Etifelmine
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
3741
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | |||
|
m725
Created by
admin on Fri Dec 15 16:28:44 UTC 2023 , Edited by admin on Fri Dec 15 16:28:44 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |